414 results on '"Semmler, Georg"'
Search Results
2. Presence of cholestasis and its impact on survival in SARS-CoV-2 associated acute respiratory distress syndrome
3. Rapid improvement of hepatic steatosis and liver stiffness after metabolic/bariatric surgery: a prospective study
4. Use of the CytoSorb adsorber in patients with acute-on-chronic liver failure
5. ELIMINATE: a PCR record-based macroelimination project for systematic recall of HCV-RNA-positive persons in Austria
6. No association of NAFLD-related polymorphisms in PNPLA3 and TM6SF2 with all-cause and cardiovascular mortality in an Austrian population study
7. Clinical course of congestive hepatopathy pre/post heart transplantation
8. Diagnostic and prognostic performance of the LiverRisk score in tertiary care
9. Hepatic venous pressure gradient predicts risk of hepatic decompensation and liver-related mortality in patients with MASLD
10. Metabolomic profiles differentiate between porto-sinusoidal vascular disorder, cirrhosis, and healthy individuals
11. Metabolic phenotyping of patients with advanced chronic liver disease for better characterization of cirrhosis regression
12. Post-treatment LSM rather than change during treatment predicts decompensation in patients with cACLD after HCV cure
13. Using liver stiffness to predict and monitor the risk of decompensation and mortality in patients with alcohol-related liver disease
14. Diverticulosis and cardiometabolic risk factors: a systematic literature review
15. The association between educational status and colorectal neoplasia: results from a screening cohort
16. sST2 Levels Show No Association with Helicobacter pylori Infection in Asymptomatic Patients: Implications for Biomarker Research
17. Austrian consensus on the diagnosis and management of portal hypertension in advanced chronic liver disease (Billroth IV)
18. Prognostic performance of non-invasive tests for portal hypertension is comparable to that of hepatic venous pressure gradient
19. Porto-sinusoidal vascular liver disorder with portal hypertension: Natural history and long-term outcome
20. Anticoagulation for splanchnic vein thrombosis in myeloproliferative neoplasms: a systematic review and meta-analysis
21. Lower free triiodothyronine (fT3) levels in cirrhosis are linked to systemic inflammation, higher risk of acute-on-chronic liver failure, and mortality
22. Platelet adhesion assessed by PFA-100 is not linked to progression of ACLD
23. Dynamics in Liver Stiffness Measurements Predict Outcomes in Advanced Chronic Liver Disease
24. Accuracy of spleen stiffness measurement for the diagnosis of clinically significant portal hypertension in patients with compensated advanced chronic liver disease: a systematic review and individual patient data meta-analysis
25. Imaging features facilitate diagnosis of porto-sinusoidal vascular disorder
26. Personalisierte Ernährung als Zukunftsmodell
27. The impact of transmembrane 6 superfamily 2 (TM6SF2) rs58542926 on liver-related events in patients with advanced chronic liver disease
28. An impaired pituitary–adrenal signalling axis in stable cirrhosis is linked to worse prognosis
29. Alcohol Abstinence Improves Prognosis Across All Stages of Portal Hypertension in Alcohol-Related Cirrhosis
30. The Sequential Application of Baveno VII Criteria and VITRO Score Improves Diagnosis of Clinically Significant Portal Hypertension
31. Inter- and intra-reader agreement for gadoxetic acid–enhanced MRI parameter readings in patients with chronic liver diseases
32. Impact of ammonia levels on outcome in clinically stable outpatients with advanced chronic liver disease
33. Outcome of Budd-Chiari Syndrome Patients Treated With Direct Oral Anticoagulants: An Austrian Multicenter Study
34. Characterization of a prothrombotic phenotype using thrombin generation and thrombin activity in cirrhosis and portal hypertension
35. Machine Learning Models predict liver steatosis but not liver fibrosis in a prospective cohort study
36. Non-invasive tests for clinically significant portal hypertension after HCV cure
37. Alpha-1 antitrypsin Pi∗Z allele is an independent risk factor for liver transplantation and death in patients with advanced chronic liver disease
38. Decompensation in Advanced Nonalcoholic Fatty Liver Disease May Occur at Lower Hepatic Venous Pressure Gradient Levels Than in Patients With Viral Disease
39. Gadoxetic acid-enhanced MRI-derived functional liver imaging score (FLIS) and spleen diameter predict outcomes in ACLD
40. Risk of further decompensation/mortality in patients with cirrhosis and ascites as the first single decompensation event
41. Additional fundophrenicopexia, after Nissen fundoplication, reduces postoperative dysphagia and re-operation rate in the long-term follow up
42. Liver Transplantation for Porto-Sinusoidal Vascular Liver Disorder: Long-term Outcome
43. The prognostic value of HVPG-response to non-selective beta-blockers in patients with NASH cirrhosis and varices
44. High histamine levels are associated with acute‐on‐chronic liver failure and liver‐related death in patients with advanced chronic liver disease.
45. Association between Diverticulosis and Colorectal Neoplasia: Analysis from a Large Austrian Database.
46. Simple blood tests to diagnose compensated advanced chronic liver disease and stratify the risk of clinically significant portal hypertension.
47. Prevalence and prognostic value of zinc and selenium deficiency in advanced chronic liver disease.
48. Clinical Course of Porto-Sinusoidal Vascular Disease Is Distinct From Idiopathic Noncirrhotic Portal Hypertension
49. PNPLA3 is the dominant SNP linked to liver disease severity at time of first referral to a tertiary center
50. The differential activation of cardiovascular hormones across distinct stages of portal hypertension predicts clinical outcomes
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.